Table 2. Clinical and therapy features of MS patients.

Patient	Age	Sex	MS years	MS phase	EDSS	Treatment	Response
MSu1	26	F	<1	RR	≤3	none	n.a.*
MSu2	59	F	<1	RR	≤3	none	n.a.
MSu3	19	F	<1	RR	≤3	none	n.a.
MSu4	60	M	32	RR	6	none	n.a.
MSu5	30	M	3	RR	≤3	none	n.a.
MSt1	32	F	5	RR	≤3	azathioprine	yes
MSt2	45	F	2	RR	≤3	glatiramer acetate	yes
MSt3	22	F	1	RR	≤3	glatiramer acetate	yes

^*: n.a.: not applicable.